4.7 Article

A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch

期刊

GENOME MEDICINE
卷 13, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13073-021-00858-2

关键词

Neisseria gonorrhoeae; Pathogenwatch; Public health; Genomics; Epidemiology; Surveillance; Antimicrobial resistance

资金

  1. Li Ka Shing Foundation (Big Data Institute, University of Oxford)
  2. Wellcome [099202]
  3. Centre for Genomic Pathogen Surveillance (CGPS)
  4. Plan GenT, Conselleria de Sanitat Universal i Salut Publica, Generalitat Valenciana (Valencia, Spain) [CDEI-06/20-B]
  5. National Institute for Health Research (UK) Global Health Research Unit on Genomic Surveillance of AMR [16_136_111]
  6. European Centre for Disease Prevention and Control
  7. National Institute for Health Research (Health Protection Research Unit)
  8. NIH/NIAID [R01 AI132606, R01 AI153521]
  9. NSF GRFP grant [DGE1745303]
  10. National Institute of Allergy and Infectious Diseases at the National Institutes of Health [1 F32 AI145157-01]
  11. Biomedical Laboratory Research and Development Service of the Department of Veterans
  12. NIH [R37 AI-021150, R01 AI-147609]
  13. World Health Organization
  14. Wellcome
  15. European Union

向作者/读者索取更多资源

The study introduces a public health-focused scheme for genomic epidemiology of N. gonorrhoeae, using integrated AMR prediction and summary data to reveal new resistant clones and transmission networks, global expansion of resistant lineages, providing a guided tool for public health surveillance.
Background Antimicrobial-resistant (AMR) Neisseria gonorrhoeae is an urgent threat to public health, as strains resistant to at least one of the two last-line antibiotics used in empiric therapy of gonorrhoea, ceftriaxone and azithromycin, have spread internationally. Whole genome sequencing (WGS) data can be used to identify new AMR clones and transmission networks and inform the development of point-of-care tests for antimicrobial susceptibility, novel antimicrobials and vaccines. Community-driven tools that provide an easy access to and analysis of genomic and epidemiological data is the way forward for public health surveillance. Methods Here we present a public health-focussed scheme for genomic epidemiology of N. gonorrhoeae at Pathogenwatch (). An international advisory group of experts in epidemiology, public health, genetics and genomics of N. gonorrhoeae was convened to inform on the utility of current and future analytics in the platform. We implement backwards compatibility with MLST, NG-MAST and NG-STAR typing schemes as well as an exhaustive library of genetic AMR determinants linked to a genotypic prediction of resistance to eight antibiotics. A collection of over 12,000 N. gonorrhoeae genome sequences from public archives has been quality-checked, assembled and made public together with available metadata for contextualization. Results AMR prediction from genome data revealed specificity values over 99% for azithromycin, ciprofloxacin and ceftriaxone and sensitivity values around 99% for benzylpenicillin and tetracycline. A case study using the Pathogenwatch collection of N. gonorrhoeae public genomes showed the global expansion of an azithromycin-resistant lineage carrying a mosaic mtr over at least the last 10 years, emphasising the power of Pathogenwatch to explore and evaluate genomic epidemiology questions of public health concern. Conclusions The N. gonorrhoeae scheme in Pathogenwatch provides customised bioinformatic pipelines guided by expert opinion that can be adapted to public health agencies and departments with little expertise in bioinformatics and lower-resourced settings with internet connection but limited computational infrastructure. The advisory group will assess and identify ongoing public health needs in the field of gonorrhoea, particularly regarding gonococcal AMR, in order to further enhance utility with modified or new analytic methods.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据